Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
1/18/2023
China Issues Notice to Encourage Foreign Capital to Set up R&D Centers...
1/18/2023
NHSA and MOHRSS Jointly Issues the 2022 National Drug Reimbursement Li...
1/18/2023
Moderna in Active Discussions with China to Supply COVID Vaccines
1/17/2023
Sinovent Pharma Sign Two Out-licensing Deals with METiS and AmMax Bio
1/16/2023
NHSA Holds 2023 National Healthcare Security Conference, Laying Out Po...
1/16/2023
The China Imperative for Multinational Companies
1/13/2023
HSMAP: Chinese MedPharm Industry Operations Report 2022
1/13/2023
PhIRDA: Early Stage Financing and Recent Startups Dominate Chinese Pha...
1/13/2023
AstraZeneca, Genertec Meheco Sign Deal for COVID Therapy Evusheld in C...
1/13/2023
MNCs to Play Key Role in Improving Cardiovascular Disease Management A...
1/12/2023
Information Collection on the 8th VBP Officially Initiated
1/12/2023
Astellas Sues Qilu Pharma in the U.S. to Block Its Generic Bladder Dru...
1/12/2023
MNC Incubators in China (PharmaDJ)
1/11/2023
Merck to Take Legal Action against Unauthorized Distributors of Its C...
1/11/2023
Merck's Covid Drug Molnupiravir Could Be Available in China Soon: Sino...
1/11/2023
Hepalink Invests $60M with TPG Biotechnology fund
1/10/2023
AmMax and Evopoint Enter into an Exclusive Option Agreement to License...
1/9/2023
NMPA Announces Package Insert Revision of Ibandronate Sodium Inj and T...
1/9/2023
Simnova and Orna Thera Collaborate to Advance Orna's Next Gen Circular...
1/9/2023
Big Pharma Preferred by Foreign Investors as China Reopens, Appetite F...
1/6/2023
Top The Chinese Pharma In-licensing Deals in 2022 (PharmCube)
1/6/2023
Top Ten Chinese Biopharma Out-licensing Deals in 2022 (PharmCube)
1/6/2023
CDE Solicits Comments on the Technical Guidelines for R&D of TCM Impro...
1/6/2023
CDE Seeks Comments on Draft Chinese Translation of ICH Guidelines M11
1/6/2023
China Issues Two New Policies on BMI Reimbursement of Covid Hospitaliz...
1/6/2023
Recent Executive Moves
1/5/2023
GSK and WuXi Biologics Enter License Deal on Multiple Novel Bi- & Mult...
1/5/2023
CANbridge Consolidates Gene Therapy Portfolio by Exercising License Op...
1/5/2023
NMPA Holds National Drug Regulatory Conference in Beijing
1/5/2023
2022 NRDL Access Negotiation Reinitiated with Industry Hoping for "Mod...
Page:
54
/
356
Total number of articles:
10665
:
[First]
[<<]
[52]
[53]
[54]
[55]
[56]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit